The hopeful buzz around the drug Remdesivir and its potential as a COVID-19 treatment was so deafening Wednesday, it triggered an unexpected surge in the financial markets. New evidence “has proven … that a drug can block this virus,” enthused Dr. Anthony Fauci, the U.S. government’s top infectious disease expert. But Canadian experts were not… Read More »
By KIP SULLIVAN, JD The notion that hospitals can reduce readmissions, and that punishing them for “excess” readmissions will get them to do that, became conventional wisdom during the 2000s on the basis of very little evidence. The Medicare Payment Advisory Commission (MedPAC) urged Congress to enact the Hospital Readmissions Reduction Program (HRRP) beginning in… Read More »
MISSED PART 1 OF THIS EXECUTIVE INTERVIEW SERIES? READ NOW to learn about Dr. Wyatt Decker’s perspectives on the state and challenges of the health care industry, where it’s smart for leaders to focus, what change means for different stakeholders across health care and lessons learned from a physician executive. Imagine this scenario: there are… Read More »
Several weeks ago, the US Preventive Services Task Force (USPSTF) issued recommendations that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and suggests that women at increased risk should be referred for counseling. The hope is that if we can identify the women at highest risk for… Read More »